Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL TELESTROKE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL TELESTROKE MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL TELESTROKE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHT
5.1 PORTERS FIVE FORCES
5.2 REGULATORY STANDARDS
5.3 TECHNOLOGICAL TRENDS
5.4 PATENT ANALYSIS
5.5 CASE STUDY
5.6 VALUE CHAIN ANALYSIS
5.7 COMPANY COMPARITIVE ANALYSIS
6 GLOBAL TELESTROKE MARKET, BY COMPONENTS
6.1 OVERVIEW
6.2 HARDWARE
6.3 SOFTWARE
6.4 SERVICES
7 GLOBAL TELESTROKE MARKET, BY FACILITIES SERVICES
7.1 OVERVIEW
7.2 ON-SITE
7.2.1 AUDIOVISUAL COMMUNICATION SYSTEM
7.2.1.1. PHONE
7.2.1.2. LAPTOP
7.2.1.3. TABLET
7.2.1.4. DESKTOP COMPUTER
7.2.1.5. VIDEO CONFERENCING DEVICE
7.2.1.6. IP CONNECTION FOR VIDEO CONFERENCING
7.2.1.7. HIGH SPEED (BROADBAND) INTERNET ACCESS
7.2.1.8. CT/BRAIN IMAGE TRANSFER CAPABILITY (DICOM SERVER)
7.2.1.9. OTHERS
7.2.2 NEUROLOGIST & ATTENDING NURSE
7.2.3 ELECTRONIC HEALTHCARE RECORD (EHR)
7.2.4 PRACTICE MANAGEMENT SYSTEM (PMS)
7.2.5 OTHERS
7.3 REMOTE
7.3.1 AUDIO VISUAL COMMUNICATION SYSTEM
7.3.1.1. PHONE
7.3.1.2. LAPTOP
7.3.1.3. DESKTOP COMPUTER
7.3.1.4. HIGH SPEED (BROADBAND) INTERNET ACCESS
7.3.1.5. OTHERS
7.3.2 WELL QUALIFIED MEDICAL PROFESSIONAL
7.3.3 OTHERS
8 GLOBAL TELESTROKE MARKET, BY CARE SETTINGS
8.1 OVERVIEW
8.2 MOBILE STROKE UNITS
8.2.1 CT SCANNER
8.2.2 ADVANCED TELEMEDICINE DEVICES
8.2.3 OTHERS
8.3 EMERGENCY DEPARTMENTS (EDS)
8.4 INTENSIVE CARE UNITS (ICUS)
8.5 MEDICAL SURGICAL UNITS
8.6 OTHERS
9 GLOBAL TELESTROKE MARKET, BY DEPLOYMENT MODE
9.1 OVERVIEW
9.2 CLOUD
9.3 ON-PREMISES
10 GLOBAL TELESTROKE MARKET, BY STROKE TYPE
10.1 OVERVIEW
10.2 ISCHEMIC
10.2.1 THROMBOTIC
10.2.2 EMBOLIC
10.3 HEMORRHAGIC
10.3.1 INTRACEREBRAL HEMORRHAGE
10.3.2 SUBARACHNOID HEMORRHAGE
10.4 TRANSIENT ISCHEMIC ATTACK (TIA)
11 GLOBAL TELESTROKE MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 PRE-HOSPITAL & HOSPITAL CARE
11.3 ADDITIONAL APPLICATIONS
11.3.1 WELLNESS
11.3.2 REMOTE MONITORING
11.3.3 DISEASE PREVENTION
11.3.4 SUBACUTE
11.3.5 REHABILITATIVE
11.3.6 REINTEGRATION INTO THE COMMUNITY PHASES
12 GLOBAL TELESTROKE MARKET, BY END USER
12.1 OVERVIEW
12.2 PROVIDERS
12.2.1 TELEHOSPITALS/TELECLINICS
12.2.2 TELEHOME
12.2.3 PRIMARY, SECONDARY, & TERTIARY CARE SETTINGS
12.2.4 OTHERS
12.3 PATIENTS
12.4 OTHERS
13 GLOBAL TELESTROKE MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 RETAIL SALES
13.4 THIRD PARTY DISTRIBUTION
14 GLOBAL TELESTROKE MARKET, BY GEOGRAPHY
14.1 GLOBAL TELESTROKE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
14.1.1 NORTH AMERICA
14.1.1.1. U.S.
14.1.1.2. CANADA
14.1.1.3. MEXICO
14.1.2 EUROPE
14.1.2.1. GERMANY
14.1.2.2. FRANCE
14.1.2.3. U.K.
14.1.2.4. ITALY
14.1.2.5. SPAIN
14.1.2.6. RUSSIA
14.1.2.7. TURKEY
14.1.2.8. BELGIUM
14.1.2.9. NETHERLANDS
14.1.2.10. NORWAY
14.1.2.11. FINLAND
14.1.2.12. SWITZERLAND
14.1.2.13. DENMARK
14.1.2.14. SWEDEN
14.1.2.15. POLAND
14.1.2.16. REST OF EUROPE
14.1.3 ASIA PACIFIC
14.1.3.1. JAPAN
14.1.3.2. CHINA
14.1.3.3. SOUTH KOREA
14.1.3.4. INDIA
14.1.3.5. AUSTRALIA
14.1.3.6. NEW ZEALAND
14.1.3.7. SINGAPORE
14.1.3.8. THAILAND
14.1.3.9. MALAYSIA
14.1.3.10. INDONESIA
14.1.3.11. PHILIPPINES
14.1.3.12. TAIWAN
14.1.3.13. VIETNAM
14.1.3.14. REST OF ASIA PACIFIC
14.1.4 SOUTH AMERICA
14.1.4.1. BRAZIL
14.1.4.2. ARGENTINA
14.1.4.3. REST OF SOUTH AMERICA
14.1.5 MIDDLE EAST AND AFRICA
14.1.5.1. SOUTH AFRICA
14.1.5.2. EGYPT
14.1.5.3. SAUDI ARABIA
14.1.5.4. U.A.E
14.1.5.5. OMAN
14.1.5.6. BAHRAIN
14.1.5.7. ISRAEL
14.1.5.8. KUWAIT
14.1.5.9. QATAR
14.1.5.10. REST OF MIDDLE EAST AND AFRICA
14.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
15 GLOBAL TELESTROKE MARKET,COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15.5 MERGERS & ACQUISITIONS
15.6 NEW PRODUCT DEVELOPMENT AND APPROVALS
15.7 EXPANSIONS
15.8 REGULATORY CHANGES
15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
16 GLOBAL TELESTROKE MARKET, SWOT & DBMR ANALYSIS
17 GLOBAL TELESTROKE MARKET, COMPANY PROFILE
17.1 EAGLE TELEMEDICINE
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 AMERICAN WELL CORPORATION
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 PROVIDENCE HEALTH & SERVICES
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 GRANVILLE HEALTH SYSTEM
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 VIDYO, INC
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 LAKEWOOD HEALTH SYSTEM
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 NEBRASKA MEDICINE
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BRISTOL-MYERS SQUIBB
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 ABBOTT
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 GENERAL ELECTRIC
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 TELESPECIALISTS
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 MERCK & CO. INC
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENT
17.13 TELADOC HEALTH, INC
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 MUSC HEALTH
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 BOSTON SCIENTIFIC CORPORATION
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 CARDINAL HEALTH
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENT
17.17 SIEMENS HEALTHCARE PRIVATE LIMITED
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
17.18 MEDVIVO GROUP LTD
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 ACCESS TELECARE, LLC
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 SUTTER HEALTH
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 BLUE SKY TELEHEALTH
17.21.1 COMPANY SNAPSHOT
17.21.2 REVENUE ANALYSIS
17.21.3 PRODUCT PORTFOLIO
17.21.4 RECENT DEVELOPMENT
17.22 MDLIVE, INC.
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
18 CONCLUSION
19 QUESTIONNAIRE
20 RELATED REPORTS
21 ABOUT DATA BRIDGE MARKET RESEARCH
